Today: 7 February 2026
Subscribe
Browse Category

Investing News 30 January 2026

Apple stock heads into next week with one big question: can AAPL dodge the memory-chip crunch?

Apple stock heads into next week with one big question: can AAPL dodge the memory-chip crunch?

Apple shares rose 0.6% to $259.92 in late Friday trading after the company projected fiscal Q2 revenue growth of 13–16%, beating analyst estimates. CEO Tim Cook cited strong iPhone demand but warned of processor supply issues and a global DRAM shortage expected to pressure margins. Apple reported quarterly revenue of $143.8 billion and EPS of $2.84. The company also acquired audio AI startup Q.ai for about $1.6 billion.
30 January 2026
·····
Merck stock rises as markets wobble — what to watch before the Feb. 3 earnings call

Merck stock rises as markets wobble — what to watch before the Feb. 3 earnings call

Merck shares rose 1.2% to $109.64 Friday afternoon, outperforming a falling S&P 500. Health care stocks attracted buyers as inflation data came in hotter than expected and Donald Trump named Kevin Warsh as Federal Reserve chair. Investors are watching for Merck’s Feb. 3 earnings call, with focus on 2026 guidance and Keytruda sales trends.
30 January 2026
·····
USA Rare Earth (USAR) stock rebounds after chairman buy as Washington price-floor rethink rattles rare-earths

USA Rare Earth (USAR) stock rebounds after chairman buy as Washington price-floor rethink rattles rare-earths

USA Rare Earth shares rose 1.4% to $22.37 Friday after chairman Michael Blitzer disclosed buying 100,000 shares on Jan. 29. The company this week raised $1.5 billion through a PIPE led by Inflection Point. Trading volume topped 26 million shares amid shifting U.S. signals on critical-minerals price support. The stock briefly jumped nearly 12% before paring gains.
30 January 2026
·····
Coca-Cola stock price climbs as investors duck into staples on Warsh Fed pick jitters

Coca-Cola stock price climbs as investors duck into staples on Warsh Fed pick jitters

Coca-Cola shares rose 1.6% to $74.63 in late trading, bucking a broader market decline as investors shifted into consumer-staples stocks amid inflation data and speculation over Trump’s Fed nominee, Kevin Warsh. Traders are watching Coca-Cola’s earnings on Feb. 10 and a Feb. 17 investor conference for further direction.
30 January 2026
·····
Starbucks stock drops near $92 as investors weigh 2028 margin push after a busy week

Starbucks stock drops near $92 as investors weigh 2028 margin push after a busy week

Starbucks shares fell about 2% Friday, trading near $92 after a volatile week. Fiscal Q1 net revenue rose 6% to $9.9 billion, with adjusted EPS at $0.56 and global same-store sales up 4%, but operating margin dropped to 10.1%. The company forecast 2026 adjusted EPS of $2.15–$2.40 and plans to close its China retail joint venture this spring. Investors remain focused on margin improvement and upcoming results.
30 January 2026
····
Why Lumentum stock is whipping around today as Wall Street gears up for earnings

Why Lumentum stock is whipping around today as Wall Street gears up for earnings

Lumentum shares rose 2.5% to $390.96 Friday after volatile trading, outpacing Morgan Stanley’s new $350 price target. The firm kept an “equal weight” rating, citing strong demand but cautioning on margins and supply constraints. Investors await second-quarter earnings on Feb. 3 for updates on profitability and capacity.
30 January 2026
·····
Procter & Gamble stock rises as Wall Street turns defensive — what traders watch next

Procter & Gamble stock rises as Wall Street turns defensive — what traders watch next

Procter & Gamble shares rose 1.1% to $151.58 Friday afternoon as investors moved into consumer-staples stocks amid inflation concerns and policy uncertainty. The S&P 500 fell 0.4% while the XLP staples ETF gained 1.2%. Senate obstacles raised the risk of a partial U.S. government shutdown before the midnight funding deadline. Investors await the Feb. 6 jobs report and further policy signals.
30 January 2026
········
AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie stock rises as ABBV heads into Feb. 4 earnings; Botox price talks in focus

AbbVie shares rose about 1% Friday, closing near $222.73 ahead of its Feb. 4 earnings report and first 2026 guidance. Investors are watching Botox pricing risks after Medicare listed it for price negotiations, and new aesthetics data from Paris. The stock dropped 2.35% Wednesday, ending a five-day rally. Goldman Sachs kept a neutral rating with a $223 target.
30 January 2026
·····
Altria stock price rebounds as MO investors size up 2026 outlook, export tax break and CEO change

Altria stock price rebounds as MO investors size up 2026 outlook, export tax break and CEO change

Altria shares rose 3.1% to $61.61 Friday, rebounding after Thursday’s earnings report sent the stock lower. The company named CFO Salvatore Mancuso as incoming CEO, effective May 14, and is expanding exports to tap a federal excise-tax rebate. Altria’s Q4 net revenue fell 2.1% to $5.846 billion, with adjusted EPS at $1.30. Market share for its on! pouches dropped to 13% as competition from Philip Morris’s Zyn intensified.
30 January 2026
·····
1 … 57 58 59 60 61 … 585

Stock Market Today

Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

7 February 2026
Keppel shares closed at S$11.64 on Friday, up 0.17%, after surging 6.1% the previous day on stronger FY2025 profit and a larger dividend plan. The company bought back 151,400 shares for about S$1.74 million. Keppel reported a 29% rise in full-year profit to S$1.02 billion and proposed a total distribution of 47 cents per share, including a special dividend partly paid in Keppel REIT units.
ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop